ArticleContemporary clinical trials communications2023

A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy.

Yu Mizuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.